EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Integrated single-dose kinome profiling data is predictive of cancer cell line sensitivity to kinase inhibitors

Chinmaya U Joisa, Kevin A Chen, Matthew E Berginski, Brian T Golitz, Madison R Jenner, Gabriela Herrera Loeza, Jen Jen Yeh, Shawn M Gomez

PeerJ · 2023

DOI: 10.7717/peerj.16342 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PeerJ, 2023. Verfasst von Chinmaya U Joisa und 7 weiteren Autor:innen. Beteiligte Einrichtung: Joint Department of Biomedical Engineering, University of North Carolina at Chapel Hill and North Carolina State University, Chapel Hill, NC, United …. Hauptthemen laut MEDLINE: Phosphotransferases, Neoplasms. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, NIDDK NIH HHS, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Protein kinase activity forms the backbone of cellular information transfer, acting both individually and as part of a broader network, the kinome. Their central role in signaling leads to kinome dysfunction being a common driver of disease, and in particular cancer, where numerous kinases have been identified as having a causal or modulating role in tumor development and progression. As a result, the development of therapies targeting kinases has rapidly grown, with over 70 kinase inhibitors approved for use in the clinic and over double this number currently in clinical trials. Understanding the relationship between kinase inhibitor treatment and their effects on downstream cellular phenotype is thus of clear importance for understanding treatment mechanisms and streamlining compound screening in therapy development. In this work, we combine two large-scale kinome profiling data sets and use them to link inhibitor-kinome interactions with cell line treatment responses (AUC/IC 50 ). We then built computational models on this data set that achieve a high degree of prediction accuracy (R 2 of 0.7 and RMSE of 0.9) and were able to identify a set of well-characterized and understudied kinases that significantly affect cell responses. We further validated these models experimentally by testing predicted effects in breast cancer cell lines and extended the model scope by performing additional validation in patient-derived pancreatic cancer cell lines. Overall, these results demonstrate that broad quantification of kinome inhibition state is highly predictive of downstream cellular phenotypes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PhosphotransferasesNeoplasmsHumansCell LineProtein Kinase InhibitorsSignal Transduction

Stichwörter der Autor:innen

CancerCell phenotypesCell signalingData integrationDrug responseDrug sensitivityKinase inhibitor treatmentMachine learningPredictive modeling

Substanzen

PhosphotransferasesProtein Kinase Inhibitors

Autor:innen und Institutionen

  • Joint Department of Biomedical Engineering, University of North Carolina at Chapel Hill and North Carolina State University, Chapel Hill, NC, United States of America.
  • Department of Surgery, University of North Carolina at Chapel Hill, Chapel Hill, NC, United States of America.
  • Department of Pharmacology, University of North Carolina at Chapel Hill, Chapel Hill, NC, United States of America.
  • Eshelman Institute for Innovation, University of North Carolina at Chapel Hill, Chapel Hill, NC, United States of America.
  • Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, United States of America.

Förderung

  • NCI NIH HHS
  • NIDDK NIH HHS
  • National Institutes of Health

Zitieren

APA

Joisa, C. U., Chen, K. A., Berginski, M. E., Golitz, B. T., Jenner, M. R., Herrera Loeza, G., Yeh, J. J., & Gomez, S. M. (2023). Integrated single-dose kinome profiling data is predictive of cancer cell line sensitivity to kinase inhibitors. PeerJ. https://doi.org/10.7717/peerj.16342

Vancouver

Joisa CU, Chen KA, Berginski ME, Golitz BT, Jenner MR, Herrera Loeza G, et al. Integrated single-dose kinome profiling data is predictive of cancer cell line sensitivity to kinase inhibitors. PeerJ. 2023. doi:10.7717/peerj.16342

BibTeX
@article{Joisa2023,
  author = {Joisa, Chinmaya U and Chen, Kevin A and Berginski, Matthew E and Golitz, Brian T and Jenner, Madison R and Herrera Loeza, Gabriela and Yeh, Jen Jen and Gomez, Shawn M},
  title = {Integrated single-dose kinome profiling data is predictive of cancer cell line sensitivity to kinase inhibitors},
  journal = {PeerJ},
  year = {2023},
  doi = {10.7717/peerj.16342}
}
Kostenlos starten →